Home |  Contact Us | Site Map

Latest News

All Releases
View Summary BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection
Mar 3, 2014
PDF 26.1 KB
View Summary BioCryst Presents BCX4161 Phase 1 Trial and Kallikrein Inhibition Assay Results
Mar 1, 2014
PDF 20.1 KB
View Summary BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results
Feb 26, 2014
PDF 80.8 KB
View Summary BioCryst Announces Peramivir NDA Acceptance by the FDA
Feb 25, 2014
PDF 17.6 KB
View Summary BioCryst to Present at Three Upcoming Investor Conferences
Feb 20, 2014
PDF 15.4 KB
View Summary BioCryst to Announce Fourth Quarter and 2013 Financial Results February 26
Feb 12, 2014
PDF 16.3 KB
View Summary BioCryst to Present at J.P. Morgan Healthcare Conference
Jan 2, 2014
PDF 15.0 KB
View Summary BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Marburg Virus Disease
Dec 30, 2013
PDF 14.2 KB
View Summary BioCryst Files Peramivir NDA for the Treatment of Influenza
Dec 20, 2013
PDF 13.7 KB
View Summary BioCryst Advances Second Generation Oral Plasma Kallikrein Inhibitors for Hereditary Angioedema into Preclinical Development
Dec 18, 2013
PDF 13.4 KB
View Summary BioCryst to Present at Two Upcoming Investor Conferences
Nov 20, 2013
PDF 10.8 KB
View Summary BioCryst Initiates OPuS-1: a Phase 2a Clinical Trial of BCX4161 in Patients with Hereditary Angioedema
Nov 7, 2013
PDF 59.6 KB
View Summary BioCryst Provides Corporate Update and Reports Third Quarter 2013 Financial Results
Nov 5, 2013
PDF 75.5 KB
View Summary BioCryst to Announce Third Quarter 2013 Financial Results November 5
Oct 23, 2013
PDF 12.1 KB
View Summary BioCryst Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop BCX4430 for the Treatment of Marburg Virus Disease
Sep 17, 2013
PDF 15.4 KB
View Summary BioCryst to Present at Morgan Stanley Global Healthcare Conference
Sep 3, 2013
PDF 11.6 KB
View Summary BioCryst Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Aug 8, 2013
PDF 23.8 KB
View Summary BioCryst Announces Full Exercise of over Allotment Option
Aug 5, 2013
PDF 12.1 KB
View Summary BioCryst to Announce Second Quarter 2013 Financial Results August 8
Aug 1, 2013
PDF 12.7 KB
View Summary BioCryst Pharmaceuticals Prices Public Offering of Common Stock
Jul 31, 2013
PDF 12.2 KB
Showing 1-20 of 143 Page: 1 2 3 ... 8  Next 20